Novo Nordisk Pharma with the new CEO
Ten post jest także dostępny w języku: polski
Since mid-May 2018, Katarzyna Kacperska has been the CEO of Novo Nordisk Pharma. She has been with the company for 21 years and previously held managerial positions in the company’s branches in Poland, Denmark and the USA.
As the key objectives of the new director’s activities, she mentions the strengthening of the development of modern methods of treatment of diabetes, obesity and haemophilia in Poland.